Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy: A Meta

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy: A Meta–Analysis

Published:2013-08 Issue:4 Volume:13 Page:271-279
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Mghanga Fabian Pius,Lan Xiaoli,Bakari Khamis Hassan,Li Chongjiao,Zhang Yongxue

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Response to therapy in breast cancer;Avril;J Nucl Med,2009

2. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902;van der Hage;J Clin Oncol,2001

3. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis;Mauri;J Natl Cancer Inst,2005

4. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy;Chagpar;Ann Surg,2006

5. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer;Yeh;AJR Am J Roentgenol,2005

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET Molecular Imaging in Breast Cancer: Current Applications and Future Perspectives;Journal of Clinical Medicine;2024-06-13

2. Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

3. Can post neoadjuvant chemotherapy 18F-FDG PET/CT predict residual cancer burden in locally advanced breast cancer?;Médecine Nucléaire;2024-05

4. ¹⁸F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy;Radiology: Imaging Cancer;2024-03-01

5. Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response;Journal of Clinical Medicine;2023-12-27